Nurse Practitioner · Eugene, OR
NPI
1104282102
Since 2016
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1200 Hilyard St
Eugene, OR, 97401
Phone (485) 205-6041
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
313 services
Medicare patients, 2024
47
Average age 66
Drug cost, 2024
$759K
1,115 prescriptions
Company payments, 2025
$19.8
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel Fields was code 99214 (office e&m - established), 91 times for 41 patients. In total Rachel Fields billed 313 services in 9 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 91 | 41 | $81.04 | $7,374 |
| 95251 Test - Miscellaneous | Office | 85 | 33 | $22.11 | $1,880 |
| 83036 Blood Count | Office | 73 | 37 | $9.52 | $695 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 33 | 27 | $10.67 | $352 |
By year: 2022 $7,888 for 132 services; 2023 $8,583 for 196 services; 2024 $13K for 313 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 73 | 37 | $9.52 | $695 |
Medicare prescription drug claims, 2024
In 2024, the drug Rachel Fields prescribed most often to Medicare patients was Ozempic (Semaglutide), with 101 prescriptions and refills. In total Rachel Fields wrote 1,115 Medicare prescriptions that cost $759K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 101 | 141 | 29 | $132K |
| Mounjaro Tirzepatide | 87 | 99 | 15 | $105K |
| Metformin Hcl Er Metformin Hcl | 85 | 227 | 31 | $796 |
| Jardiance Empagliflozin | 64 | 119 | 23 | $70K |
| Tresiba Flextouch U-100 Insulin Degludec | 56 | 95 | 19 | $30K |
| Tresiba Flextouch U-200 Insulin Degludec | 47 | 65 | 11 | $55K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 47 | 104 | 24 | $5,631 |
| Insulin Lispro Generic | 35 | 54 | 12 | $3,052 |
| Glipizide Generic | 31 | 60 | Under 11 | $551 |
| Pioglitazone Hcl Generic | 30 | 62 | 12 | $226 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 27 | 55 | 11 | $1,846 |
| Insulin Degludec Pen (U-200) Insulin Degludec | 26 | 33 | Under 11 | $9,000 |
| Metformin Hcl Generic | 26 | 80 | 13 | $418 |
| Novolog Insulin Aspart | 25 | 34 | Under 11 | $4,794 |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 25 | 36 | Under 11 | $31K |
Brand drugs: 833 claims; generic drugs: 189 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel Fields $19.8 ($19.8 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $19.8.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $19.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.